Concepedia

Jay Bolden

JB

Statistics

Publications

5

Citations

132

H-Index

5

Active since

2014

Affiliations

Eli Lilly (United States)(Current)

Jay Bolden is an author at Eli Lilly (United States) specializing in endotoxin control, endotoxin quantification, and endotoxin assays.

Publications per year

2014–2023

5

Publications

5

Endotoxin recovery using limulus amebocyte lysate (LAL) assay

Jay Bolden, Rob E. Warburton, Robert W. Phelan et al. · Biologicals · 2016 · 45 citations

, , +8

Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products

Jay Bolden, Kelly Smith · PDA Journal of Pharmaceutical Science and Technology · 2017 · 40 citations

, , +12

Results of a harmonized endotoxin recovery study protocol evaluation by 14 BioPhorum Operations Group (BPOG) member companies

Jay Bolden, Michael E. Knight, Shahrzad Stockman et al. · Biologicals · 2017 · 23 citations

, , +8

Evidence Against a Bacterial Endotoxin Masking Effect in Biologic Drug Products by Limulus Amebocyte Lysate Detection

Jay Bolden, MARK EUGENE CLAERBOUT, Matthew K Miner et al. · PDA Journal of Pharmaceutical Science and Technology · 2014 · 13 citations

, , +14

Barriers to the Use of Recombinant Bacterial Endotoxins Test Methods in Parenteral Drug, Vaccine and Device Safety Testing

Elizabeth Baker, Jessica Ponder, Johannes Oberdorfer et al. · Alternatives to Laboratory Animals · 2023 · 11 citations · Full text

, , +13

1–5 of 5